Haematological Traits in Symptomatic and Asymptomatic COVID-19 Positive Patients for Predicting Severity and Hospitalization

References

• Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020;56(2):106054. doi:10.1016/j.ijantimicag.2020.106054
   PubMed Web of Science ®Google Scholar
• Worldometers. COVID live update; 2021.
   Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS? Critical Care. 2020;24(1):1–5. doi:10.1186/s13054-020-02911-9
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020;323(21):2195–2198. doi:10.1001/jama.2020.7202
   PubMed Web of Science ®Google Scholar
• Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region—case series. New Engl J Med. 2020;382(21):2012–2022. doi:10.1056/NEJMoa2004500
   PubMed Web of Science ®Google Scholar
• Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612–1614. doi:10.1001/jama.2020.4326
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu X, Li Y, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020;201(11):1430–1434. doi:10.1164/rccm.202003-0736LE
   PubMed Web of Science ®Google Scholar
• Zhang D, Guo R, Lei L, et al. COVID‐19 infection induces readily detectable morphologic and inflammation‐related phenotypic changes in peripheral blood monocytes. J Leukoc Biol. 2020. doi:10.1101/2020.03.24.20042655
   Web of Science ®Google Scholar
• Foldes D, Hinton R, Arami S, Bain BJ. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19). Am J Hematol. 2020;95(7):861–862. doi:10.1002/ajh.25834
   PubMed Web of Science ®Google Scholar
• Mitra A, Dwyre DM, Schivo M, et al. Leukoerythroblastic reaction in a patient with COVID −19 infection. Am J Hematol. 2020;95:999–1000. doi:10.1002/ajh.25793
   PubMed Web of Science ®Google Scholar
• Zini G, Bellesi S, Ramundo F, d’Onofrio G. Morphological anomalies of circulating blood cells in COVID −19. Am J Hematol. 2020;95:870–872. doi:10.1002/ajh.25824
   PubMed Web of Science ®Google Scholar
• Kaur G, Sandeep F, Olayinka O, Gupta G. Morphologic changes in circulating blood cells of COVID-19 patients. Cureus. 2021;13(2):e13416.
   PubMed Web of Science ®Google Scholar
• Nazarullah A, Liang C, Villarreal A, Higgins RA, Mais DD. Peripheral blood examination findings in SARS-CoV-2 infection. Am J Clin Pathol. 2020;154(3):319–329. doi:10.1093/ajcp/aqaa108
   PubMed Web of Science ®Google Scholar
• Klok F, Kruip M, Van der Meer N, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150. doi:10.1016/j.thromres.2020.04.041
   PubMed Web of Science ®Google Scholar
• Smilowitz NR, Kunichoff D, Garshick M, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021;42(23):2270–2279. doi:10.1093/eurheartj/ehaa1103
   PubMed Web of Science ®Google Scholar
• Nardi M, Tomlinson S, Greco MA, Karpatkin S. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell. 2001;106(5):551–561. doi:10.1016/S0092-8674(01)00477-9
   PubMed Web of Science ®Google Scholar
• Assinger A, Kral JB, Yaiw KC, et al. Human Cytomegalovirus–platelet interaction triggers toll-like receptor 2–dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol. 2014;34(4):801–809. doi:10.1161/ATVBAHA.114.303287
   PubMed Web of Science ®Google Scholar
• Guo L, Feng K, Wang Y, et al. Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection. Mucosal Immunol. 2017;10(6):1529–1541. doi:10.1038/mi.2017.1
   PubMed Web of Science ®Google Scholar
• Chaipan C, Soilleux EJ, Simpson P, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol. 2006;80(18):8951–8960.
   PubMed Web of Science ®Google Scholar
• Simon AY, Sutherland MR, Pryzdial EL. Dengue virus binding and replication by platelets. Blood, J Am Soc Hematol. 2015;126(3):378–385.
   Google Scholar
• Zhang S, Liu Y, Wang X, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):1–22. doi:10.1186/s13045-020-00954-7
   PubMed Web of Science ®Google Scholar
• Man MA, Rajnoveanu R-M, Motoc NS, et al. Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients. PLoS One. 2021;16(6):e0252599. doi:10.1371/journal.pone.0252599
   PubMed Web of Science ®Google Scholar
• Simadibrata DM, Pandhita BAW, Ananta ME, Tango T. Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysis. J Intensive Care Soc. 2020;23:20–26.
   Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. MedRxiv. 2020. doi:10.1101/2020.02.10.20021584
   Google Scholar
• Kosikowska U, Rybojad P, Stępień–Pyśniak D, Żbikowska A, Malm A. Changes in the prevalence and biofilm formation of Haemophilus influenzae and Haemophilus parainfluenzae from the respiratory microbiota of patients with sarcoidosis. BMC Infect Dis. 2016;16(1):1–13. doi:10.1186/s12879-016-1793-7
   PubMed Web of Science ®Google Scholar
• Tian S, Liu H, Liao M, et al. Analysis of Mortality in Patients with COVID-19: Clinical and Laboratory Parameters. Open Forum Infectious Diseases. Oxford University Press US; 2020.
   Google Scholar
• Song J-W, Zhang C, Fan X, et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020;11(1):1–10. doi:10.1038/s41467-020-17240-2
   PubMed Web of Science ®Google Scholar
• Yang H, Xu Y, Li Z, Yan L, Wang J, Liao P. The clinical implication of dynamic hematological parameters in COVID-19: a retrospective study in Chongqing, China. Int J Gen Med. 2021;14:4073. doi:10.2147/IJGM.S321292
   PubMed Web of Science ®Google Scholar
• Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID‐19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797–806. doi:10.1002/jmv.25783
   PubMed Web of Science ®Google Scholar
• Li R, Tian J, Yang F, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China. J Clin Virol. 2020;127:104363. doi:10.1016/j.jcv.2020.104363
   PubMed Web of Science ®Google Scholar
• Liu C-L, Lu Y-T, Peng M-J, et al. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest. 2004;126(2):509–517. doi:10.1378/chest.126.2.509
   PubMed Web of Science ®Google Scholar
• Al-Abdallat MM, Payne DC, Alqasrawi S, et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014;59(9):1225–1233. doi:10.1093/cid/ciu359
   PubMed Web of Science ®Google Scholar
• Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. New Engl J Med. 2020;383(25):2451–2460. doi:10.1056/NEJMcp2009575
   PubMed Web of Science ®Google Scholar
• Sheng L, Wang X, Tang N, Meng F, Huang L, Li D. Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study. Clin Exp Med. 2021;21(1):35–39. doi:10.1007/s10238-020-00662-z
   PubMed Web of Science ®Google Scholar
• Thomas T, Stefanoni D, Dzieciatkowska M, et al. Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. J Proteome Res. 2020;19(11):4455–4469. doi:10.1021/acs.jproteome.0c00606
   PubMed Web of Science ®Google Scholar
• Russo A, Tellone E, Barreca D, Ficarra S, Laganà G. Implication of COVID-19 on erythrocytes functionality: red blood cell biochemical implications and morpho-functional aspects. Int J Mol Sci. 2022;23(4):2171. doi:10.3390/ijms23042171
   PubMed Web of Science ®Google Scholar
• Delgado-Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res. 2020;51(5):384–387. doi:10.1016/j.arcmed.2020.04.019
   PubMed Web of Science ®Google Scholar
• Rabaan AA, Al-Ahmed SH, Haque S, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med. 2020;28(2):174–184.
   PubMedGoogle Scholar
• Panesar N. What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients? Med Hypotheses. 2008;71(2):298–301. doi:10.1016/j.mehy.2008.03.019
   PubMed Web of Science ®Google Scholar
• Chu H, Zhou J, Wong BH-Y, et al. Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2016;213(6):904–914. doi:10.1093/infdis/jiv380
   PubMed Web of Science ®Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi:10.1093/cid/ciaa248
   PubMed Web of Science ®Google Scholar
• Shahid Z, Kalayanamitra R, McClafferty B, et al. COVID‐19 and older adults: what we know. J Am Geriatr Soc. 2020;68(5):926–929. doi:10.1111/jgs.16472
   PubMed Web of Science ®Google Scholar
• Kang S-J, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154. doi:10.3947/ic.2020.52.2.154
   PubMed Web of Science ®Google Scholar
• Asghar MS, Khan NA, Haider Kazmi SJ, et al. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Community Hospital Int Med Perspect. 2020;10(6):514–520. doi:10.1080/20009666.2020.1816276
   PubMed Web of Science ®Google Scholar
• Huang J, Cheng A, Lin S, Zhu Y, Chen G. Individualized prediction nomograms for disease progression in mild COVID‐19. J Med Virol. 2020;92(10):2074–2080. doi:10.1002/jmv.25969
   PubMed Web of Science ®Google Scholar
• Qian G-Q, Yang N-B, Ding F, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM Int J Med. 2020;113(7):474–481. doi:10.1093/qjmed/hcaa089
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994
   PubMed Web of Science ®Google Scholar
• Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218. doi:10.1016/j.kint.2020.05.006
   PubMed Web of Science ®Google Scholar
• Dupont A, Rauch A, Staessens S, et al. Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19. Arterioscler Thromb Vasc Biol. 2021;41(5):1760–1773. doi:10.1161/ATVBAHA.120.315595
   PubMed Web of Science ®Google Scholar
• Ackermann M, Anders H-J, Bilyy R, et al. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ. 2021;28(11):3125–3139. doi:10.1038/s41418-021-00805-z
   PubMed Web of Science ®Google Scholar
• Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–1089. doi:10.1001/jamainternmed.2020.2033
   PubMed Web of Science ®Google Scholar
• Shang Y, Liu T, Wei Y, et al. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine. 2020;24:100426. doi:10.1016/j.eclinm.2020.100426
   PubMedGoogle Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. New Engl J Med. 2020;383(2):120–128. doi:10.1056/NEJMoa2015432
   PubMed Web of Science ®Google Scholar
• Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18(8):1217–1223. doi:10.1038/nm.2843
   PubMed Web of Science ®Google Scholar
• Garsen M, Rops AL, Rabelink TJ, Berden JH, van der Vlag J. The role of heparanase and the endothelial glycocalyx in the development of proteinuria. Nephrol Dial Transpl. 2014;29(1):49–55. doi:10.1093/ndt/gft410
   PubMed Web of Science ®Google Scholar
• Nicolai L, Leunig A, Brambs S, et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020;142(12):1176–1189. doi:10.1161/CIRCULATIONAHA.120.048488
   PubMed Web of Science ®Google Scholar
• Skendros P, Mitsios A, Chrysanthopoulou A, et al. Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130(11):6151–6157. doi:10.1172/JCI141374
   PubMed Web of Science ®Google Scholar
• Middleton EA, He X-Y, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169–1179. doi:10.1182/blood.2020007008
   PubMed Web of Science ®Google Scholar
• Dolhnikoff M, Duarte-Neto AN, De Almeida Monteiro RA, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thrombosis Haemostasis. 2020;18(6):1517–1519. doi:10.1111/jth.14844
   PubMed Web of Science ®Google Scholar
• Leppkes M, Knopf J, Naschberger E, et al. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020;58:102925. doi:10.1016/j.ebiom.2020.102925
   PubMed Web of Science ®Google Scholar
• Mousavi SA, Rad S, Rostami T, et al. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 2020;25(1):383–388. doi:10.1080/16078454.2020.1833435
   PubMed Web of Science ®Google Scholar
• Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;40:110–114. doi:10.1016/j.ajem.2020.11.058
   PubMed Web of Science ®Google Scholar
• Sarkar S, Kannan S, Khanna P, Singh AK. Role of platelet‐to‐lymphocyte count ratio (PLR), as a prognostic indicator in COVID‐19: a systematic review and meta‐analysis. J Med Virol. 2022;94(1):211–221. doi:10.1002/jmv.27297
   PubMed Web of Science ®Google Scholar